whitepaper
Artificial Intelligence (AI) is revolutionizing the life sciences industry, offering unprecedented transformation in drug discovery and development. Our latest whitepaper reviews the evolution and the recent transformative impact of AI technologies in drug discovery and considers the latest policy guidance in the United States and European Union. Download today to learn more about:
Historical Context: Explore the evolution of AI in drug discovery, from the introduction of computer-aided drug design (CADD) to modern AI methodologies.
Current Applications: Understand how AI is being utilized to repurpose existing drugs, identify new therapeutic targets, and design novel molecules. Discover the promising future of AI in personalized medicine and predictive modeling.
Policy Guidance: Gain insights into the latest US and EU policies guiding the integration of AI in drug discovery, emphasizing responsible innovation, regulatory support, and ethical considerations.
This whitepaper provides a comprehensive analysis of global policy developments, including:
Historical Context: Explore the evolution of AI in drug discovery, from the introduction of computer-aided drug design (CADD) to modern AI methodologies.
Current Applications: Understand how AI is being utilized to repurpose existing drugs, identify new therapeutic targets, and design novel molecules. Discover the promising future of AI in personalized medicine and predictive modeling.
Policy Guidance: Gain insights into the latest US and EU policies guiding the integration of AI in drug discovery, emphasizing responsible innovation, regulatory support, and ethical considerations.
This whitepaper provides a comprehensive analysis of global policy developments, including:
- The FDA’s proactive guidance and upcoming draft regulations on AI/ML in drug development.
- The European Union’s AI Act and EMA’s reflections on AI in regulatory decision-making.
- The role of global AI Safety Institutes in ensuring safe and ethical AI applications in life sciences.
Unlock the full potential of AI in drug discovery by understanding the regulatory landscape and emerging opportunities. Download our whitepaper to explore the future of pharma and integrate cutting-edge AI strategies into your development pipeline.
Complete the form to access the full whitepaper
For more insights on drug development, target identification, and real-world data integration, visit our Lifebit Blog.
×
Download Full White Paper
Read our review of EU and US policy guidance on AI in drug discovery.
